SCHEMBL7301418

SCHEMBL7301418

COc1cccc(S(=O)(=O)C(CC(=O)NOC(C)(C)C)Cc2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 8/20 0.61
PDE4B Q07343 8/20 0.61
PDE4C Q08493 8/20 0.61
PDE4D Q08499 8/20 0.61
MMP1 P03956 6/20 0.61
MMP2 P08253 5/20 0.61
MMP3 P08254 5/20 0.61
MMP13 P45452 2/20 0.46
MMP9 P14780 1/20 0.44
TAS2R14 Q9NYV8 1/20 0.43
CNR1 P21554 1/20 0.43
BACE1 P56817 2/20 0.42
CTSD P07339 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
MEP1B Q16820 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305191 0.89 MMP1 (0.76) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7311602 0.88 MMP1 (0.62) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7311479 0.86 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7301051 0.85 MMP1 (0.57) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7308348 0.85 MMP1 (0.62) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7302387 0.82 MMP2 (0.60) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7308096 0.79 MMP1 (0.57) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7311006 0.78 MMP1 (0.56) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7311001 0.76 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL6824624 0.76 MMP2 (1.00) PDE4APDE4BPDE4CPDE4DMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed